- Home
- HIHO vs CYCN Comparison
HIHO vs CYCN Comparison
Compare HIHO & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HIHO
- CYCN
- Stock Information
- Founded
- HIHO 1990
- CYCN 2018
- Country
- HIHO Hong Kong
- CYCN United States
- Employees
- HIHO N/A
- CYCN N/A
- Industry
- HIHO Industrial Machinery/Components
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- HIHO Industrials
- CYCN Health Care
- Exchange
- HIHO Nasdaq
- CYCN Nasdaq
- Market Cap
- HIHO 8.2M
- CYCN 7.5M
- IPO Year
- HIHO 1996
- CYCN N/A
- Fundamental
- Price
- HIHO $1.81
- CYCN $2.58
- Analyst Decision
- HIHO
- CYCN
- Analyst Count
- HIHO 0
- CYCN 0
- Target Price
- HIHO N/A
- CYCN N/A
- AVG Volume (30 Days)
- HIHO 2.1K
- CYCN 26.5K
- Earning Date
- HIHO 01-21-2025
- CYCN 03-04-2025
- Dividend Yield
- HIHO 6.67%
- CYCN N/A
- EPS Growth
- HIHO N/A
- CYCN N/A
- EPS
- HIHO N/A
- CYCN N/A
- Revenue
- HIHO $7,345,000.00
- CYCN $2,000,000.00
- Revenue This Year
- HIHO N/A
- CYCN N/A
- Revenue Next Year
- HIHO N/A
- CYCN N/A
- P/E Ratio
- HIHO N/A
- CYCN N/A
- Revenue Growth
- HIHO 11.36
- CYCN N/A
- 52 Week Low
- HIHO $1.70
- CYCN $1.27
- 52 Week High
- HIHO $2.88
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- HIHO 42.86
- CYCN 46.16
- Support Level
- HIHO $1.83
- CYCN $2.44
- Resistance Level
- HIHO $1.88
- CYCN $2.68
- Average True Range (ATR)
- HIHO 0.03
- CYCN 0.20
- MACD
- HIHO -0.01
- CYCN 0.02
- Stochastic Oscillator
- HIHO 9.09
- CYCN 29.46
About HIHO Highway Holdings Limited
Highway Holdings Ltd is a holding company. The company is a manufacturer of metal, plastic, electric and electronic components for original equipment manufacturers (OEM) and contract manufacturers. Its operating segment includes Metal stamping and mechanical OEM and Electric OEM. The metal stamping segment focuses on the manufacturing and sale of metal parts and components. The company generates maximum revenue from the Metal stamping and mechanical OEM segment. Geographically, it derives a majority of its revenue from Europe and also has a presence in Hong Kong and China, North America, and Other Asian countries.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.